The Assessment of Endovascular Therapies in Ischemic Stroke: Management, Problems and Future Approaches

Ischemic stroke accounts for over 80% of all strokes and is one of the leading causes of mortality and permanent disability worldwide. Intravenous administration of recombinant tissue plasminogen activator (rt-PA) is an approved treatment strategy for acute ischemic stroke of large arteries within 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Popiela, Tadeusz J., Krzyściak, Wirginia, Pilato, Fabio, Ligęzka, Anna, Bystrowska, Beata, Bukowska-Strakova, Karolina, Brzegowy, Paweł, Muthusamy, Karthik, Kozicz, Tamas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999747/
https://www.ncbi.nlm.nih.gov/pubmed/35407472
http://dx.doi.org/10.3390/jcm11071864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999747/
https://www.ncbi.nlm.nih.gov/pubmed/35407472
http://dx.doi.org/10.3390/jcm11071864

Ejemplares similares